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Molecular-level understanding of body weight
control is essential for combating obesity. We show
that female mice lacking tyrosine phosphatase
epsilon (RPTPe) are protected from weight gain
induced by high-fat food, ovariectomy, or old age
and exhibit increased whole-body energy expendi-
ture and decreased adiposity. RPTPe-deficient
mice, in particular males, exhibit improved glucose
homeostasis. Female nonobese RPTPe-deficient
mice are leptin hypersensitive and exhibit reduced
circulating leptin concentrations, suggesting that
RPTPe inhibits hypothalamic leptin signaling
in vivo. Leptin hypersensitivity persists in aged,
ovariectomized, and high-fat-fed RPTPe-deficient
mice, indicating that RPTPe helps establish
obesity-associated leptin resistance. RPTPe associ-
ates with and dephosphorylates JAK2, thereby
downregulating leptin receptor signaling. Leptin
stimulation induces phosphorylation of hypotha-
lamic RPTPe at its C-terminal Y695, which drives
RPTPe to downregulate JAK2. RPTPe is therefore
an inhibitor of hypothalamic leptin signaling in vivo,
and provides controlled negative-feedback regula-
tion of this pathway following its activation.
INTRODUCTION
High-calorie, fat-rich diets play central roles in the obesity
pandemic. The hormone leptin, which is produced in white
adipose tissue, is an established regulator of body weight and
energy balance (Friedman and Halaas, 1998; Spiegelman and
Flier, 2001). Binding of leptin to its receptor in the hypothalamus
activates the JAK2 tyrosine kinase, which leads to phosphoryla-
tion of the receptor and activation of downstream signaling,
including the STAT3, ERK, and PI3-kinase pathways (Myers
et al., 2008). Leptin stimulates a class of hypothalamic neurons562 Cell Metabolism 13, 562–572, May 4, 2011 ª2011 Elsevier Inc.to produce pro-opiomelanocortin (POMC), which suppresses
food intake and increases energy expenditure. In parallel, leptin
inhibits production of the agouti-related protein (AgRP) and
neuropeptide Y (NPY) in a separate set of hypothalamic neurons;
both peptides stimulate food intake and inhibit energy expendi-
ture (Konner et al., 2009; Morton et al., 2006; Myers et al., 2009).
Leptin affects body weight also by targeting neurons outside the
hypothalamus (Myers et al., 2009), such as by inhibiting
synthesis of serotonin in the brainstem (Yadav et al., 2009). In
addition, hypothalamic leptin signaling affects glucose homeo-
stasis by improving peripheral insulin sensitivity (Buettner and
Camacho, 2008). Obesity is often associated with leptin resis-
tance, in which the response of the hypothalamic leptin receptor
to its ligand is reduced. As a result, most obese humans exhibit
elevated concentrations of circulating leptin and respond poorly
to the exogenously administered hormone (Myers et al., 2008).
Leptin signaling is under tight control of molecules that target
the receptor or its downstream effectors. For example, SOCS3,
whose expression is induced by leptin, inhibits signaling by
binding JAK2 and the leptin receptor (Myers et al., 2008), while
the non-receptor-type tyrosine phosphatase PTP1B inhibits
leptin signaling by targeting JAK2. Inactivation of PTP1B in
mice causes reduced adiposity and increased sensitivity toward
leptin and insulin (Bence et al., 2006; Cheng et al., 2002; Elchebly
et al., 1999; Klaman et al., 2000; Xue et al., 2009; Zabolotny et al.,
2002). In contrast, the PH and SH2 domain-containing protein
SH2B1 supports signaling by the receptor. Accordingly, mice
lacking SH2B1 are obese and suffer from hyperglycemia, insulin
and leptin resistance, and hyperlipidemia (Ren et al., 2007).
The importance of tyrosine phosphorylation in regulating leptin
receptor signaling suggests that protein tyrosine phosphatases
(PTPs) (Alonso et al., 2004; Tonks, 2006), which antagonize tyro-
sine kinase activity, may affect body weight. The SH2 domain-
containingphosphataseSHP2promotes leptin receptor signaling
by binding to Y985 of the leptin receptor and thus activating ERK;
however, SHP2 also downregulates signaling by inhibiting JAK2/
STAT3 activity (Myers et al., 2008; Zhang et al., 2004). The pheno-
type of mice lacking neuronal SHP2—increased adiposity,
decreased leptin sensitivity, and reduced energy expenditure—
indicates that overall SHP2 upregulates leptin signaling. PTP1B
and SHP2 show that individual PTPs may support or inhibit
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et al., 2008; Zhang et al., 2004). PTPs may affect body weight
also by regulating other pathways. For example, mice lacking
the dual-specificity PTP MKP-1 exhibit enhanced energy expen-
diture and resistance to diet-induced obesity, despite not
showing leptin-related abnormalities (Wu et al., 2006).
In this study we examined whether PTP epsilon, a phospha-
tase that downregulates insulin receptor signaling in cells
(Aga-Mizrachi et al., 2007; Andersen et al., 2001; Nakagawa
et al., 2005), helps regulate body weight. We show that female
mice lacking PTPe (EKO mice) are protected from weight gain
that normally occurs following a high-fat diet (HFD), ovariectomy,
or aging. EKO female mice are markedly leptin sensitive; circu-
lating levels of leptin are reduced in obese, ovariectomized, or
aged EKO mice, indicating that these mice remain leptin sensi-
tive under physiological conditions associated with leptin resis-
tance. EKO mice of both genders also exhibit improved
response to glucose load. At the molecular level RPTPe associ-
ates with and dephosphorylates JAK2, thereby downregulating
leptin receptor signaling. Leptin-induced phosphorylation of
RPTPe at its C-terminal Y695 enhances this process. We
conclude that RPTPe is a physiological inhibitor of leptin
signaling in the hypothalamus, which acts by targeting JAK2
following activation of the leptin receptor.
RESULTS
Female EKO Mice Are Protected
from Challenge-Induced Weight Gain
Mice that genetically lack PTPe (EKO mice) are born in Mende-
lian ratios, gain weight normally, and maintain proper weight as
adults (Tiran et al., 2006, and data not shown). However, at
14–16 months of age, EKO female mice weigh 16% less than
matched wild-type (WT) controls; a similar trend exists in male
mice (Figure 1A). In order to examine if body weight regulation
is abnormal in EKO mice, we subjected young adult (4-month-
old) mice to a HFD. When placed on this diet for 11 weeks,
female EKO mice gained 55% less weight than matched WT
control mice; no similar resistance to HFD was noted in male
EKO mice (Figures 1B and 1C). Female rodents gain weight
significantly following ovariectomy (e.g., Ainslie et al., 2001).
WT and EKO female mice aged 3 months were ovariectomized
and followed for 10 weeks. At the end of this period, WT ovariec-
tomized mice added 32% to their starting weight, while no
weight gain was observed in ovariectomized EKO mice (Fig-
ure 1D). Similar protection from weight gain was observed
when groups of WT and EKO mice were ovariectomized at the
ages of 7 or 14–16 months (Figure S1, available online, and
data not shown). The older group of EKO mice combined the
effects of both old age and ovariectomy: these mice weighed
less than their WT counterparts prior to ovariectomy, and gained
no weight following the procedure (Figure S1). We conclude that
female mice lacking PTPe are protected from weight gain that
occurs in old age and when body weight homeostasis is chal-
lenged following a HFD or ovariectomy.
In all the above cases, protection of EKO mice from weight
gain was associated with reduced body fat content. HFD, ovari-
ectomy, or old age significantly increased the relative weight of
abdominal white fat pads of WT female mice; the effect in EKOCmice was either markedly reduced or entirely absent (Figure 1E).
Similar results were obtainedwhen thewhole-body fat content of
elderly (>14 months) WT and EKO female mice was examined
pre- and postovariectomy by dual energy X-ray absorptiometry
(DEXA) scanning (Figure S1). A trend for lighter abdominal fat
pads that did not reach statistical significance was noted in
elderly EKO males (Figure 1E). These findings correlated with
a smaller size of adipose cells in the fat pads of EKO mice fed
a HFD, whose average cross-sectional area was reduced by
25.3% (Figure 1F). No abnormalities were detected in brown
adipose tissue of EKO mice (data not shown).
Increased Metabolic Rates of EKO Mice
EKO mice consume the same amount of food as their age- and
gender-matched WT counterparts (Figures S2A and S2B), sug-
gesting that the resistance to weight gain in EKO mice may be
due to increased energy expenditure. In order to examine this
possibility, female WT and EKO mice were examined by indirect
calorimetry.Micewereplaced in individual cages and their oxygen
consumption, CO2 production, heat production, food consump-
tion, andphysical activityweremeasuredcontinuously for a period
of72hr.When fed regular chow,EKOmicedisplayedstrong trends
for increased consumption of oxygen, increased CO2 production,
and increased heat production (Figures 2A–2C). These trends
reached clear statistical significance when the mice were fed
high-fat food (Figures 2A–2C). The respiratory exchange ratio
(RER), which reflects the relative use of fat or carbohydrates as
a sourceof energy,was similar in bothgenotypes, although, asex-
pected, the shift from regular lab chow to a HFD lowered this ratio
significantly (Figure 2D). The physical activity ofWT and EKOmice
was similar (Figures S2C and S2D). We conclude that female EKO
miceexhibit a pre-existing trend for increasedenergyexpenditure.
This difference is strengthened significantly when EKO mice are
challenged with a HFD, consistent with the reduced weight gain
of these mice in this experimental paradigm.
Decreased Circulating Leptin Concentrations
in EKO Mice
In order to determine the basis for resistance to weight gain in
female EKO mice, we examined these mice in greater detail.
Female EKOmice fed regular chow exhibited a very strong trend
for reduced circulating leptin concentrations, both in absolute
terms and after normalizing to body weight (Table 1). When WT
mice were challenged with a HFD, ovariectomized, or aged
past 14 months, their concentrations of circulating leptin
increasedsignificantly, consistentwith theestablishmentofa lep-
tin-resistant state. In contrast, leptin concentrations were signif-
icantly lower in EKOmice that were similarly challenged (Table 1).
Trends for reduced leptin concentrationswere found inmale EKO
mice. Importantly, reduced concentrations of circulating leptin
do not simply reflect reduced adiposity of EKO mice, since the
results shown in Table 1 were normalized to body weight and
since a very strong trend for reduced leptin concentrations was
found in nonobese EKO females of normal weight. These results
suggest that female EKO mice are leptin hypersensitive.
Improved Glucose Homeostasis in EKO Mice
As both body weight and leptin affect insulin sensitivity, we
examined whether EKO mice exhibit altered glucoseell Metabolism 13, 562–572, May 4, 2011 ª2011 Elsevier Inc. 563
Figure 1. Female EKO Mice Are Protected
from Stress-Induced Weight Gain
(A) EKO female mice aged 14–16 months are
thinner than their WT counterparts (n = 12 per
genotype, **p = 0.0003 by Student’s t test).
(B) Four-month-old WT or EKO female mice were
fed a HFD or regular chow (CD) for 11 weeks. The
starting weights of mice from all experimental
groups were similar (mean ± SE, EKO; HFD, 19.9 ±
0.5 gr; EKO, CD, 18.9 ± 0.7 gr; WT, HFD, 19.3 ± 0.5
gr; WT, CD, 20.9 ± 0.8 gr; n = 8, HFD; n = 5, CD).
EKO mice fed HFD gain less weight than WT mice
fed similar food (p = 0.004, by two-way ANOVA
with Fisher’s Least Significant Difference test).
(C) Similar to (B), performed on WT and EKO male
mice. WT HFD and EKO HFD data are not distinct,
analyzed as in (B).
(D) Three-month-old female mice were ether
ovariectomized (OVX) or sham-operated (S). N = 5
mice per genotype and treatment. The starting
weights of all groups of mice were similar; EKO
OVX mice gain less weight than WT OVX mice
(p < 0.0001, analyzed as in B).
(E) Weights of abdominal fat pads (normalized to
body weight) of WT or EKOmice studied in (A)–(D).
NS, nonsignificant (n = 5–12 mice per bar;
*p = 0.02; **p% 0.003; ***p = 0.0003 by Student’s
t test).
(F) Sections of paraffin-embedded abdominal
white fat pads of WT and EKO mice fed a HFD
were stained with hematoxylin and eosin and
analyzed using the OsteoII software package
(Bioquant, Nashville, TN). The mean cross-section
area of EKO cells was reduced by 25.3% relative
to WT cells (cross-sectional areas [mean ± SE, in
square microns], WT, 4559.1 ± 119.7 [n = 1501
cells]; EKO, 3635.6 ± 69.7 [n = 1708 cells];
p = 1.2 3 (10 exp  12) by Student’s t test). In this
and in all subsequent figures, error bars
represent SE.
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were similar in plasma of WT and EKO mice of both genders
that were fed regular chow (Table 1). Exposing EKO and WT
mice to a HFD for 12 weeks significantly increased their fasting
concentrations of circulating glucose and insulin; however,
glucose and insulin concentrations in male EKO mice fed
a HFD were markedly reduced relative to WT mice, suggesting
insulin hypersensitivity (Table 1). When challenged with an intra-
peritoneal glucose load, EKO male mice displayed significantly
improved responses when fed regular or high-fat food. Similar
but weaker findings were noted in female EKO mice (Figures
3A–3D). Injection of insulin resulted in a rapid and similar drop
in circulating glucose concentrations in both WT and EKO
mice; however, glucose concentrations remained lower for
a longer time period in male EKO mice fed a HFD (Figures 3E–
3H). Intraperitoneal injection of insulin resulted in a more564 Cell Metabolism 13, 562–572, May 4, 2011 ª2011 Elsevier Inc.pronounced increase in phosphorylation
of AKT in liver and muscle tissue of EKO
male mice (Figures 3I and 3J), confirming
the insulin hypersensitivity of these mice.
Overall, these results indicate that EKOmice show improved glucose homeostasis and increased insulin
sensitivity.
EKO Mice Are Leptin Hypersensitive
Reduced circulating leptin concentrations correlated most
closely with the weight gain resistance phenotype of EKO
mice; both were most prevalent in EKO females that had been
challenged metabolically. Since reduced leptin concentration
in circulation may reflect increased sensitivity of leptin signaling
in the hypothalamus, we examined this issue in greater depth.
PTPe mRNA is found in the arcuate, paraventricular, and ventro-
medial hypothalamic nuclei inmice (Figures 4A–4F), in which lep-
tin acts. Dual in situ hybridization for PTPe and the leptin receptor
in the arcuate nucleus revealed colocalization of both mRNAs in
cells in this region (Figures 4G–4I); most of the cells that ex-
pressed the leptin receptor coexpressed RPTPe. Protein blot
Figure 2. EKO Female Mice Exhibit Increased Whole-Body Energy
Expenditure by Indirect Calorimetry
Four-month-old WT or EKO female mice were fed a HFD or regular chow
(control), and their production of carbon dioxide (VCO2), oxygen consumption
(VO2), and heat production were analyzed for 72 hr (p % 0.037, n = 6 per
genotype and treatment). HFD lowered the respiratory exchange rate (RER) in
both genotypes (p < 0.0001). Feeding and mobility of WT and EKO mice were
similar (Figure S2). Data are from the night, active phase.
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expression of the receptor-type form of PTPe, RPTPe; this
form is entirely absent from hypothalami of EKOmice (Figure 4J).
No compensatory changes were found in expression of RPTP
alpha, a PTP that is closely related to RPTPe, or of PTP1B or
SHP2, which affect hypothalamic leptin signaling (Figure 4J).
No obvious compensatory changes in expression of otherTable 1. Concentrations of Circulating Leptin, Glucose, and Insulin
Females
Control HFD Old Age
Plasma leptin
(pg/ml per gr BW)
WT 92.1 ± 13.7 168.9 ± 35.9 403.2 ± 51.8
EKO 51.8 ± 11.4
(0.053)
76.9 ± 10.1
(0.014)
180.6 ± 19.9
(0.0006)
Fasting glucose
(mg/dl)
WT 57.3 ± 2.3 70.1 ± 2.4
EKO 55.9 ± 2.4 (NS) 67.4 ± 4.4 (NS)
Fasting insulin
(ng/ml)
WT 0.37 ± 0.11 0.79 ± 0.21
EKO 0.37 ± 0.05 (NS) 0.51 ± 0.10 (NS)
Plasma leptin concentrations in 4-month-old mice that were fed regular cho
and followed for 10 additional weeks (OVX), or were 14–17 months old (old
regular chow (control) and in mice fed high-fat food for 5–7 additional weeks
n = 4–17 mice per genotype, gender, and treatment. P values compare the
CPTPs were noted in EKO mouse hypothalamus (Figure S3A).
RPTPe is therefore present in the hypothalamic nuclei that
respond to leptin and participate in regulating body weight. Of
note, expression of RPTPe protein in adipose tissue, where lep-
tin is produced, is almost undetectable (Figure S3B).
In order to determine if EKO female mice are hypersensitive to
leptin, we stimulated them with leptin in acute and chronic
administration protocols. Four-month-old female WT and EKO
mice of similar weight were injected intraperitoneally with various
doses of leptin or with vehicle alone (PBS). After 30–45 min the
mice were sacrificed and hypothalamic STAT3 phosphorylation
was examined as readout for leptin receptor activation (Figures
4K and 4L). Basal phosphorylation of STAT3, which was similar
in hypothalami of WT and EKO mice injected with PBS,
increased significantly following injection of leptin. However, lep-
tin-induced STAT3 phosphorylation was 38% stronger in EKO
hypothalami (Figure 4L), confirming their leptin hypersensitivity.
Similar results were obtained inmice fed a HFD (data not shown),
indicating that leptin hypersensitivity persists also in obese EKO
animals. In contrast, male EKO andWTmice responded similarly
in this system (Figure 4L). Chronic administration of leptin tomice
for several days reduced food intake in female EKO mice more
significantly than similarly treated WT mice (Figure 4M); a trend
for more significant loss in body weight was observed in EKO
mice (data not shown). We conclude, therefore, that female
EKOmice are leptin hypersensitive. Importantly, the hypothalami
of WT and EKO mice that had not been stimulated with leptin
contained similar amounts of mRNAs for the leptin receptor
and for peptides that it regulates (NPY, AGRP, POMC) (Fig-
ure S4). Leptin hypersensitivity of EKOmice therefore most likely
originates in aberrant regulation of leptin receptor signaling
following its activation and not, for example, in increased expres-
sion of the receptor. Collectively, the above findings indicate that
leptin hypersensitivity precedes the body weight phenotype of
EKO mice and is not caused by it.RPTPe Downregulates Leptin Receptor Signaling
The increase in hypothalamic STAT3 phosphorylation following
stimulation of EKO mice with leptin strongly suggests thatin WT and EKO Mice
Males
OVX Control HFD Old Age
439.8 ± 63.1 77.4 ± 18.5 743 ± 120 720 ± 39
229.3 ± 83.8
(0.045)
59.5 ± 7.2 (NS) 629 ± 128 (NS) 412 ± 178 (NS)
69.2 ± 4.9 102.2 ± 6.5
65.9 ± 2.7 (NS) 80.8 ± 4.4 (0.014)
0.29 ± 0.06 1.47 ± 0.27
0.35 ± 0.09 (NS) 0.80 ± 0.24 (0.033)
w (control), fed a HFD for 12 additional weeks (HFD), were ovariectomized
age). Fasting serum and insulin were measured in 4-month-old mice fed
. All mice were fasted for 16–22 hr prior to sampling. Data are mean ± SE,
EKO value with the WT value above it. NS, nonsignificant.
ell Metabolism 13, 562–572, May 4, 2011 ª2011 Elsevier Inc. 565
Figure 3. Glucose Metabolism in EKO Mice
(A–D) Glucose tolerance test. Eight-week-oldWT or EKOmice were injected IP
with glucose (1.5 gr/Kg body weight); blood glucose concentrations were
measured at the indicated times.
(E–H) Mice were injected with insulin (0.75 U/Kg body weight); blood glucose
was followed as above.Mice were fed regular lab chow (A, C, E, G) or a HFD for
5–7 weeks before the experiment (B, D, F, H). Differences between WT and
EKO graphs marked with asterisks are significant by two-way ANOVA with
Fischer’s Least Significant Difference test.
(I and J) Male mice fed regular chow were injected IP with insulin. Phosphor-
ylation of AKT at T308 was analyzed by protein blotting. AKT phosphorylation
at Ser473 was similar in both genotypes (data not shown). Shown are mean +
SE; *p% 0.044 by Student’s t test, n = 5–10 mice per bar.
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elements further upstream, such as JAK2 or the leptin receptor
itself. In agreement, expression of RPTPe in 293T cells signifi-
cantly decreased leptin-induced phosphorylation of STAT3
(at Y705), JAK2 (at Y1007/1008), and AKT/PKB (at T308) (Figures
5A–5C), sites that are required for activation of their respective
molecules. Presence of RPTPe also decreased JAK2-induced
phosphorylation of the leptin receptor (Figure S5A). As expected,
the catalytically inactive, substrate-trapping mutant D302A
RPTPe did not reduce phosphorylation of JAK2 and STAT3 in566 Cell Metabolism 13, 562–572, May 4, 2011 ª2011 Elsevier Inc.similar experiments (Figure S5B). Purified RPTPe, but not its
inactive mutant D302A RPTPe, dephosphorylated purified
JAK2 when the two proteins were mixed in vitro (Figure 5D and
Figure S5C), suggesting that JAK2 is a substrate of RPTPe.
JAK2 and RPTPe formed a stable complex in 293T cells in the
absence of the leptin receptor (Figure 5E); D302A RPTPe also
bound JAK2 (Figure S5D). Purified RPTPe and JAK2 physically
associate in vitro, suggesting that this association is direct (Fig-
ure S5C). Although presence of the leptin receptor or its activa-
tion is not strictly required for the RPTPe-JAK2 association, the
receptor does coprecipitate with the JAK2-RPTPe complex (Fig-
ure 5E). Furthermore, in some cases (e.g., Figure 5E), presence
of the receptor strengthened somewhat the association between
RPTPe and JAK2. We conclude that JAK2 and RPTPe are
present in the same molecular complex, and that RPTPe down-
regulates leptin receptor signaling by dephosphorylating JAK2.
Yet, we cannot rule out at the present time the possibility that
RPTPe also targets the leptin receptor or STAT3.
Leptin-Induced C-Terminal Phosphorylation of RPTPe
Increases Its Ability to Target JAK2
The physiological role of PTPe can be affected by phosphoryla-
tion at its C-terminal tyrosine (Y695 in RPTPe = Y638 in the non-
receptor isoform, cyt-PTPe; Berman-Golan and Elson, 2007;
Granot-Attas et al., 2009). In order to examine if leptin stimulation
induces phosphorylation of RPTPe in the hypothalamus, we
injected young adult nonobese WT female mice with leptin,
isolated hypothalamic tissue at various times afterwards, and
examined phosphorylation of endogenous RPTPe at Y695.
Basal phosphorylation of RPTPe was observed in these studies;
phosphorylation increased significantly following leptin injection,
reaching maximal levels after 60 min and declining thereafter
(Figures 6A and 6B). Leptin-induced phosphorylation of RPTPe
in WT mice was more prominent in mice fed a HFD than in
mice fed regular food (Figure 6B). This finding is consistent
with RPTPe playing a role in establishing the leptin-resistant
state in obese mice, as discussed below.
Leptin-induced phosphorylation of RPTPe was observed also
in 293 cells expressing the leptin receptor and JAK2; leptin-
induced phosphorylation was prevented by omission of exoge-
nous JAK2 (Figure 6C). Together with phosphorylation of purified
RPTPe at Y695 by purified JAK2 in vitro (Figure 6D), these results
indicate that JAK2 can phosphorylate RPTPe downstream of the
activated leptin receptor. Importantly, while WT RPTPe induced
dephosphorylation of JAK2 in cells treated with leptin, its
nonphosphorylatable mutant Y695F RPTPe did so less effi-
ciently (Figure 6E); this suggests that phosphorylation of RPTPe
at Y695 is important for its ability to act upon JAK2. WT RPTPe
was also more capable of reducing STAT3 phosphorylation (Fig-
ure 6E). We conclude that activation of the leptin receptor
induces phosphorylation of RPTPe at Y695, thus increasing the
ability of RPTPe to dephosphorylate JAK2 as part of a negative
feedback regulatory mechanism for hypothalamic leptin
signaling.
DISCUSSION
The pre-existing leptin hypersensitivity in young female EKO
mice that precedes their obesity-resistant phenotype, and the
Figure 4. Female EKO Mice Are Leptin
Hypersensitive
(A–I) PTPe is expressed in the hypothalamus. WT
mouse brain was hybridized to an antisense (A, B,
D, E) or sense (negative control, C and F) PTPe
cRNA probe. (A)–(C), Bregma 0.82 mm; (D)–(F),
Bregma 1.46 mm. (B) and (E) show higher
magnifications of (A) and (D), respectively. (G)–(I)
show double in situ analysis in the arcuate nucleus
using probes for PTPe (red) and leptin receptor
(green) mRNAs. PVN, paraventricular nucleus.
VM, ventromedial nucleus. Arc, arcuate nucleus.
Bars, 250 mm (A, C, D, F) or 125 mm (B and E).
(J) RPTPe protein is expressed in the hypothal-
amus. Hypothalamic tissue from 2-month-old
female WT and EKOmice was analyzed by protein
blotting. POMC serves as a hypothalamic marker.
(K) Acute leptin treatment: 4-month-old female
WT or EKO mice were fasted for 16 hr and then
injected intraperitoneally with vehicle (PBS) or
leptin at the indicated doses. Hypothalami were
collected 30 min later.
(L) Female and male WT and EKO mice were in-
jected with leptin (5 mg/gr body weight) or PBS;
hypothalami were collected 45 min later. N =
11–12 mice per bar. *p = 0.036 by Student’s t test.
(M) Chronic leptin treatment: following an adap-
tation period, 4-month-old female mice were in-
jected with PBS or leptin twice daily starting on
day 0. From day 6 all mice were injected with PBS.
Shown is the daily food intake relative to day 0. The
graphs for leptin-treated WT and EKO mice are
distinct (p < 0.05) by two-way ANOVA with
Fischer’s Least Significant Difference test. N =
8–12 mice per genotype and treatment.
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mice are metabolically challenged strongly suggest that RPTPe
downregulates leptin receptor signaling in the hypothalamus.
High-fat food, ovariectomy, and old age are associated with
weight gain, increased concentrations of circulating leptin, and
decreased sensitivity to leptin (Ainslie et al., 2001; Carrascosa
et al., 2009; Kelesidis et al., 2010). The pre-existing leptin hyper-
sensitivity of EKO mice counteracts at least in part the leptin-
resistant state that is induced in WT mice in these situations,
and most likely leads to reduced weight gain that is observed
in EKO mice. RPTPe is therefore part of the molecular mecha-
nism that induces leptin resistance when mice are challenged
as above.
Our molecular studies strongly suggest that RPTPe inhibits
leptin receptor signaling by targeting the downstream kinase
JAK2 in a manner supported by phosphorylation of RPTPe at
Y695. RPTPe coimmunoprecipitates with JAK2 and dephos-
phorylates it at Y1007/1008. Y1007 is located within the activa-Cell Metabolism 13, 562tion loop of JAK2, and its phosphorylation
is required for activation of the kinase
(Feng et al., 1997). Dephosphorylation of
JAK2 at this site by RPTPe is then consis-
tent with RPTPe inhibiting leptin receptor
signaling and with the leptin sensitivity
phenotype of EKO mice. The issues of
whether RPTPe targets additional tyro-sine residues in JAK2 and whether RPTPe targets the leptin
receptor directly require further studies.
Activation of the leptin receptor in vivo in the mouse hypothal-
amus and in cultured cells induces phosphorylation of RPTPe at
its C-terminal Y695; JAK2 participates in this process, either
alone or in concert with other kinases. Phosphorylation of RPTPe
has clear physiological consequences, since the nonphosphor-
ylatable Y695F RPTPe is less able to dephosphorylate JAK2
downstream of the leptin receptor. Leptin-induced phosphoryla-
tion of RPTPe is increased in obese, leptin-resistant WT mice
(Figure 6B), suggesting that hypothalamic RPTPe is recruited
more strongly to downregulate leptin receptor signaling in obese
mice. This finding is consistent with a role for RPTPe in establish-
ing the leptin-resistant state in obesity in WT mice, and with
reduced leptin resistance in obese PTPe-deficient mice. Collec-
tively, the above data support amodel (Figure 6G) bywhich JAK2
and RPTPe associate constitutively prior to activation of the lep-
tin receptor; it is possible that RPTPe helps downregulate leptin–572, May 4, 2011 ª2011 Elsevier Inc. 567
Figure 5. RPTPe Reduces Phosphorylation
of JAK2 and STAT3 and Associates with
JAK2
(A) (Top) 293T HEK cells expressing the leptin
receptor, HA-tagged JAK2, and FLAG-RPTPe
were stimulated (+) or not () for 5 min with 100 nM
leptin and analyzed for JAK2 phosphorylation at
Y1007/1008. (Bottom) Bar diagram summarizing
results of four similar experiments; *p < 0.05 by
Student’s t test.
(B and C) 293 cells expressing the leptin receptor
and RPTPe, showing phosphorylation of endoge-
nous STAT3 at Y705 or endogenous AKT/PKB at
T308.
(D) PTPe dephosphorylates JAK2 in vitro. Purified
PTPe intracellular domain (WT or D302A [DA]) and
beads carrying autophosphorylated JAK2 were
incubated at 30C for 30 min and analyzed by
SDS-PAGE. JAK2 was completely dephosphory-
lated after 60 min incubation (Figure S5C).
(E) RPTPe and JAK2 physically associate in cells.
293T HEK cells expressing leptin receptor, JAK2,
and FLAG-RPTPe were stimulated (+) or not () for
5 min with 100 nM leptin. RPTPe was immuno-
precipitated, and presence of associated JAK2
and leptin receptor was determined.
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RPTPe is phosphorylated at Y695, at least in part by JAK2; phos-
phorylation directs RPTPe to dephosphorylate JAK2 at Y1007/
1008, thus providing negative feedback that returns activated
leptin signaling to baseline. RPTPe has potent autodephosphor-
ylating activity (Berman-Golan and Elson, 2007), which may
counter its phosphorylation by JAK2 and limit its effect. In the
absence of RPTPe, the extent of leptin resistance induced by
obesity is reduced, and mice gain less weight as compared to
their WT obese counterparts. The precise molecular mechanism
by which phosphorylation of RPTPe directs this PTP to act upon
JAK2 is not clear at the present time. Y695F RPTPe and WT
RPTPe can each be found in a molecular complex with JAK2
and the leptin receptor (Figure 6F). Moreover, WT and Y695F
RPTPe are catalytically active, and the Y695E mutant of RPTPe,
which mimics in part phosphorylation of RPTPe at Y695, exhibits
unaltered kinetic properties toward para-nitrophenylphosphate
(PNPP) (Berman-Golan and Elson, 2007). This information
suggests that phosphorylation at Y695 affects neither the ability
of RPTPe to associate with JAK2 nor its enzymatic activity.
Phosphorylation does, however, allow RPTPe to bind other568 Cell Metabolism 13, 562–572, May 4, 2011 ª2011 Elsevier Inc.molecules (e.g., Grb2 [Toledano-Katchal-
ski and Elson, 1999]), one or more of
which might facilitate its activity toward
JAK2.
C-terminal phosphorylation of PTPe
downstream of activated membranal
receptors induces this phosphatase to
regulate other signaling events as well.
Phosphorylation of RPTPe downstream
of activated Neu/ErbB2 in mouse
mammary tumor cells induces it todephosphorylate and activate Src, which is required for main-
taining full transformation of these cells (Berman-Golan and
Elson, 2007; Gil-Henn and Elson, 2003). Phosphorylation of the
nonreceptor isoform of PTPe, cyt-PTPe, at the same site
following integrin activation in osteoclasts is required for full acti-
vation of Src, for proper organization of podosomes in these cells
and for bone degradation (Chiusaroli et al., 2004; Granot-Attas
et al., 2009). A general signaling module then emerges in which
activation of a membranal receptor results in C-terminal phos-
phorylation of PTPe,which induces PTPe to perform aphysiolog-
ical role. This study links this module with regulation of body
weight and provides the first example where phosphorylation
of PTPe inhibits, rather than supports, the transduced signal.
Our findings indicate that EKO mice of both genders exhibit
improved glucose homeostasis. This result is expected in older
EKOmice and in EKOmice that were fed a HFD or were ovariec-
tomized due to their relatively reduced adiposity. However,
similar findings in young male and female EKO mice of normal
weight imply that this effect is independent of the weight pheno-
type. Furthermore, increased activation of AKT in liver and
muscle following injection of insulin to EKO mice implies that
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ings by us and by others have shown that PTPe downregulates
insulin receptor signaling in CHO cells (Andersen et al., 2001),
in hepatocytes (Nakagawa et al., 2005), and in muscle cells
(Aga-Mizrachi et al., 2007). This study extends these results to
the whole-animal level by showing that lack of PTPe improves
regulation of blood glucose homeostasis and insulin response
in liver and muscle. Nonetheless, improved insulin sensitivity in
EKO livermay be due to altered rates of insulin secretion ormight
be related to leptin hypersensitivity, as leptin regulates insulin-
mediated hepatic glucose production (Buettner and Camacho,
2008). Further studies, including tissue-specific deletion of
PTPe, are required to address this issue. The neuronal insulin
receptor is a potent regulator of body weight. However, we
believe that altered insulin signaling does not cause the body
weight phenotype of EKO mice, since this phenotype is found
mainly in EKO females, while improved glucose metabolism is
found in EKO mice of both genders.
PTPe affects body weight primarily in female mice. An oppo-
site gender preference was described in one of the studies of
PTP1B-deficient mice, and was attributed either to diet or to
the genetic background of the mice used (Klaman et al., 2000).
While these factors may affect EKO mice, other possibilities
exist. For example, estrogen regulates energy status by affecting
leptin sensitivity in the brain (Gao and Horvath, 2008; Gao et al.,
2007), raising the possibility that interactions between estrogen
and leptin signaling may amplify the body weight phenotype of
EKO mice in females. Gender-specific differences exist also in
the relative importance of signaling by leptin or insulin to body
weight regulation, with leptin playing a more prominent role in
females (Clegg et al., 2003; Shi et al., 2009). Further studies
are required to address this issue.
Mice lacking PTP1B fed high-fat food exhibited increased
energy expenditure and decreased adiposity, gained less
weight, and were more insulin sensitive than WT mice (Elchebly
et al., 1999; Klaman et al., 2000). Further studies showed that
PTP1B-deficient mice are leptin hypersensitive and that PTP1B
dephosphorylates JAK2 (Cheng et al., 2002; Zabolotny et al.,
2002), and that these phenotypes were due at least partly to
PTP1B regulating leptin signaling in brain neurons (Banno
et al., 2010; Bence et al., 2006; Xue et al., 2009). The apparent
similarity in the roles of PTP1B and RPTPe in leptin signaling
may reflect the need for tight control of this critical signaling
pathway by multiple PTPs. Nonetheless, both PTPs differ mark-
edly in terms of structure and regulation, leaving open the possi-
bility that they may regulate leptin signaling under different phys-
iological circumstances and thus perform complementary roles.
Administration of leptin to obese humans generally fails to
reduce body weight due to obesity-induced leptin resistance
(Kelesidis et al., 2010). Targeted inhibition of those PTPs, such
as RPTPe, which inhibit leptin receptor signaling and which are
important for establishing leptin resistance in the obese state,
may increase the usefulness of treating obesity with leptin.EXPERIMENTAL PROCEDURES
Mice
Gene-targeted mice lacking all forms of PTPe (EKO mice, C57Bl/6 genetic
background) were used (Peretz et al., 2000). Mice were kept in a pathogen-Cfree facility and fed regular chow (2018SC; Harlan Teklad, Madison, WI,
USA; 18% of calories from fat) and water ad libitum. On occasion mice were
fed high-fat food (diet 03307 [58.6% of calories from fat], Harlan Teklad; or
diet D12492 [60% of calories from fat], Research Diets, New Brunswick, NJ).
For indirect calorimetry, mice were fed either diet D12492 or amatched control
diet (diet 12450B, 10%calories from fat; ResearchDiets). All experimentswere
approved by the Institutional Animal Care and Use Committee of the Weiz-
mann Institute in accordance with Israeli law.
Reagents
The following cDNAs were used: mouse WT and Y695F RPTPe (Toledano-
Katchalski and Elson, 1999), D302A RPTPe (Gil-Henn and Elson, 2003), and
HA-tagged human JAK2 and leptin receptor (generous gifts of Dr. Michel
Tremblay, McGill University, Canada). The following monoclonal antibodies
were used: anti-FLAG (clone M2, Sigma-Aldrich, St. Louis, MO, USA),
POMC (Acris antibodies, Herford, Germany), PTP1B (clone 15, BD Biosci-
ences, San Jose, CA), actin (clone C4, MP Biochemicals, Illkirch, France),
antioxidized PTP (Persson et al., 2004) (clone 335636, R&D Systems), and
STAT3 and pY705 STAT3 (clones 124H6 and 3E3, respectively, Cell Signaling
Technology, Danvers, MA). Polyclonal antibodies used included the following:
PTPe/PTPa (Elson and Leder, 1995), pY695 RPTPe (Berman-Golan and Elson,
2007), anti-HA (probe Y11, Santa Cruz Biotechnology, Santa Cruz, CA), JAK2
and pY1007/1008 JAK2 (Millipore, Billerica, MA, USA), and AKT and pThr308
AKT (Cell Signaling Technology). Leptin was purchased from Protein Labora-
tories Rehovot, Ltd., Rehovot, Israel.
Metabolic Rate and Physical Activity
Indirect calorimetry, locomotor activity, and food and water intake were
measured using the Labmaster system (TSE Systems, Bad Homburg,
Germany). Mice were placed in individual cages with a light/dark cycle of
12 hr. Following 48 hr adaptation, the system determined O2 consumption,
CO2 production, heat production, RER, and food and water consumption for
each mouse individually for a further 72 hr. A photobeam-based monitoring
system was used to track animal movement (including rearing and climbing).
Glucose and Insulin Tolerance Tests
Mice were fasted overnight and injected IP with either glucose (1.5 gr/kg body
weight) or insulin (0.75 U/kg body weight; Novo Nordisk, Denmark). Whole
venous blood was obtained from the orbital sinus. Blood glucose concentra-
tions were measured with an automated glucometer (Freestyle, Abbott Dia-
betes Care, Alameda, CA). Leptin and insulin were measured by ELISA (Chrys-
tal Chem, Downers Grove, IL).
Leptin Stimulation
For acute stimulation, mice were housed individually, starved overnight, and
injected IP with leptin (5 mg/gr body weight). Mice were sacrificed by cervical
dislocation and their hypothalami were dissected and snap frozen in liquid
nitrogen. For chronic stimulation mice were housed individually and injected
i.p. with PBS twice daily. After return of body weight and food consumption
to baseline (after 7–9 days), PBS was replaced with leptin (1 mg/gr body weight
per injection, 2 mg/gr body weight per day); control mice continued to receive
PBS injections. After 6 days, all mice received PBS. Body weights and food
consumption were measured daily.
Tissue Culture
293 cells were grown in Dulbecco’s modified Eagle’s medium (Sigma-Aldrich)
supplemented with 10% fetal calf serum (Invitrogen), 4 mM glutamine, 50 U/ml
penicillin, and 50 mg/ml streptomycin at 37C, 5%CO2. Cells were transfected
using the calcium phosphate method (Chen and Okayama, 1988).
Protein Analysis
Samples were lysed in buffer A (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1%
Nonidet P-40), supplemented with protease inhibitors (1 mM N-[a-aminoethyl]
benzene-sulfonyl fluoride, 40 mM bestatin, 15 mME64, 20 mM leupeptin, 15 mM
pepstatin; Sigma-Aldrich) and 0.5mMsodium pervanadate. Immunoprecipita-
tion (Berman-Golan and Elson, 2007) and SDS-PAGE and protein blotting
(Gil-Henn and Elson, 2003) were performed as described. Lysates to be
analyzedwith the antioxidized PTP antibody (Persson et al., 2004) were treatedell Metabolism 13, 562–572, May 4, 2011 ª2011 Elsevier Inc. 569
Figure 6. RPTPe Is Phosphorylated at Y695 Following Activation of the Leptin Receptor
(A) Four-month-old female WT mice were injected IP with leptin (5 mg/gr body weight). Hypothalami were isolated at the indicated times and analyzed with
a pY695-PTPe specific antibody.
(B) Bar diagram showing increased phosphorylation of RPTPe at Y695 at t = 60 min following leptin injection in mice fed chow diet (CD) or fatty food (HFD).
N = 7–10 mice per bar; *p% 0.0065 by Student’s t test.
(C) 293T cells were transfected with cDNAs for the leptin receptor, JAK2, and WT or Y695F RPTPe, and stimulated with 100 nM leptin for 5 min as indicated.
pY695 PTPe was determined by protein blotting.
(D) Purified JAK2 phosphorylates purified RPTPe at Y695. Purified RPTPe (WT or Y695F [YF]) and JAK2were incubated for 30min at 37C and assayed for RPTPe
phosphorylation by protein blotting.
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PTPe Inhibits Hypothalamic Leptin Signalingwith 0.5mM sodium pervanadate for 10min prior to SDS-PAGE. Purification of
PTPe from 293 cells was performed as described (Sines et al., 2007). HA-JAK2
was immunoprecipitated from 293 cells with an HA antibody; phosphorylated
JAK2 was isolated from cells pretreated with leptin. For in vitro dephosphory-
lation of pJAK2, 30 ng of PTPe and 25 ml of beads carrying pY JAK2 were incu-
bated at 30C for 30–60 min in a buffer consisting of 50 mM MES (pH 7.3),
0.5 mM dithiothreitol, 0.5 mg/ml bovine serum albumin. For in vitro phosphor-
ylation of PTPe, 30 ng of PTPe and 25 ml of beads carrying JAK2 were
incubated at 37 degrees for 30 min in a buffer consisting of 60 mM HEPES
(pH 7.6), 5 mM MgCl2, 5 mM MnCl2, 0.125 mM sodium peroxyvanadate,
100 mM ATP, 1.25 mM DTT.
Statistics
Data were analyzed using a two-tailed Student’s t test or by ANOVA as indi-
cated, with significance set at p = 0.05. Data are shown as mean ± SE.
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